Clinical Trial Update: Prospective, Multicenter, Single-Arm Study of Aortic Arch Pathology Reconstruction [NA]

View source ↗

Summary

This is a prospective, multicenter, single-arm clinical trial evaluating aortic arch pathology reconstruction, sponsored by Shanghai MicroPort Endovascular MedT…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Arch Disease

Snippet

Sponsor: Shanghai MicroPort Endovascular MedTech（Group）Co., Ltd | Conditions: Aortic Arch Disease | NA | Status: NOT_YET_RECRUITING